DekaBank Deutsche Girozentrale - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,684
-19.7%
53,129
+6.3%
0.00%
-20.0%
Q2 2023$2,096
+18.4%
50,0000.0%0.01%
+25.0%
Q1 2023$1,771
+27.5%
50,000
+25.0%
0.00%0.0%
Q4 2022$1,389
-99.9%
40,0000.0%0.00%
-33.3%
Q3 2022$2,175,000
+27.9%
40,000
+21.2%
0.01%
+20.0%
Q2 2022$1,700,000
-25.7%
33,000
+4.1%
0.01%
-16.7%
Q1 2022$2,288,000
-22.3%
31,700
+26.3%
0.01%
-14.3%
Q4 2021$2,944,000
-12.0%
25,100
+2.4%
0.01%
-22.2%
Q3 2021$3,346,000
-14.3%
24,5000.0%0.01%
-18.2%
Q2 2021$3,905,000
+99.8%
24,500
-7.5%
0.01%
+83.3%
Q1 2021$1,954,000
+91.2%
26,500
+41.0%
0.01%
+50.0%
Q4 2020$1,022,000
+205.1%
18,800
+19.7%
0.00%
+300.0%
Q3 2020$335,000
-32.5%
15,700
-51.8%
0.00%
-50.0%
Q2 2019$496,000
-20.5%
32,600
+63.0%
0.00%
-50.0%
Q1 2019$624,000
+212.0%
20,000
+22.7%
0.00%
+300.0%
Q4 2018$200,000
-67.9%
16,300
-18.5%
0.00%
-75.0%
Q3 2018$624,000
-31.0%
20,000
-40.3%
0.00%
-33.3%
Q2 2018$905,000
+40.3%
33,500
+9.8%
0.01%
+50.0%
Q1 2018$645,000
+748.7%
30,500
+563.0%
0.00%
+300.0%
Q4 2017$76,0000.0%4,6000.0%0.00%0.0%
Q3 2017$76,000
+1.3%
4,6000.0%0.00%0.0%
Q2 2017$75,0004,6000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders